文献速递妇科

良性微创子宫切除术中的非阿片类疼痛管理:一项系统综述

Non-opioid pain management in benign minimally invasive hysterectomy: A systematic review.
PubMed 文献 · Am J Obstet Gynecol · 2016-12-30

该系统综述检索PubMed、ClinicalTrials.gov和Cochrane数据库至2016年11月9日,纳入24项研究,评估良性微创子宫切除术后非阿片类药物的镇痛效果。基于质量不一且有限的数据,静脉对乙酰氨基酚、抗惊厥药和地塞米松显示阿片类药物节约效应;酮咯酸在腹腔镜子宫切除术中结果不一致;宫颈旁阻滞在阴道子宫切除术中提供镇痛益处。文献异质性和矛盾性使确定性结论难以得出,需要更多高质量研究。

要点

  • 静脉对乙酰氨基酚、抗惊厥药和地塞米松显示阿片类药物节约效应。
  • 酮咯酸在腹腔镜子宫切除术中结果不一致。
  • 宫颈旁阻滞在阴道子宫切除术中提供镇痛益处。

核心结论

  • 由于文献的异质性和矛盾性,难以得出确定性结论。
  • 明确需要更多高质量研究来评估每种药物类型对子宫切除术后疼痛控制的效果。

研究设计与样本

  • 系统综述,检索PubMed、ClinicalTrials.gov和Cochrane数据库,使用MeSH词包括「postoperative pain」「perioperative pain」「postoperative analgesia」「pain management」「pain control」「minimally invasive gynecologic surgery」和「hysterectomy」。
  • 纳入所有PubMed发表的涉及微创子宫切除术的研究,截至2016年11月9日;研究限于良性微创子宫切除术评估非阿片类药物疗法。
  • 最初识别1155项研究,24项研究符合所有纳入标准。
  • 两名评审员独立完成每项研究的特征和结果深度评估,使用Cochrane协作网的Grades of Recommendation, Assessment, Development and Evaluation方法进行风险偏倚评估和质量评级。

主要发现

  • 基于质量不一且有限的数据,静脉对乙酰氨基酚、抗惊厥药和地塞米松显示阿片类药物节约效应。
  • 酮咯酸在腹腔镜子宫切除术中显示不一致的结果。
  • 宫颈旁阻滞在阴道子宫切除术中提供疼痛减轻益处。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 文献具有异质性和矛盾性,难以得出确定性结论。
  • 数据有限且质量不一。
  • 需要更多高质量研究来评估每种药物类型对子宫切除术后疼痛控制的效果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Less postoperative pain typically is associated with a minimally invasive hysterectomy compared with a laparotomy approach; however, poor pain control can still be an issue. Multiple guidelines exist for managing postoperative pain, yet most are not specialty-specific and are based on procedures that bear little relevance to a minimally invasive hysterectomy. OBJECTIVE: The purpose of this study was to determine whether there is enough quality evidence within the benign gynecology literature to make non-opioid pain control recommendations for women who undergo a benign minimally invasive hysterectomy. STUDY APPRAISAL AND SYNTHESIS METHODS: We queried PubMed, ClinicalTrials.gov, and Cochrane databases using MeSH terms: "postoperative pain," "perioperative pain," "postoperative analgesia," "pain management," "pain control," "minimally invasive gynecologic surgery," and "hysterectomy." A manual examination of references from identified studies was also performed. All PubMed published studies that involved minimally invasive hysterectomies through November 9, 2016, were included. This systematic review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Studies were restricted to benign minimally invasive hysterectomies evaluating non-opioid pharmacologic therapies. Primary outcomes included amount of postoperative analgesics consumed and postoperative pain scores. Two reviewers independently completed an in-depth evaluation of each study for characteristics and results using an established database, according to inclusion/exclusion criteria. A risk assessment was performed, and a quality rating was assigned with the use of the Cochrane Collaboration's Grades of Recommendation, Assessment, Development and Evaluation approach. RESULTS: Initially 1155 studies were identified, and 24 studies met all inclusion criteria. Based on limited data of varying quality, intravenous acetaminophen, anticonvulsants and dexamethasone demonstrate opioid-sparing benefits; ketorolac shows mixed results in laparoscopic hysterectomies. Paracervical blocks provide pain-reducing benefits in vaginal hysterectomies. CONCLUSIONS: Convincing conclusions are difficult to draw because of the heterogeneous and contradictory nature of the literature. There is a clear need for more high-quality research that will evaluate each medication type for posthysterectomy pain control.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Blanton E, Lamvu G, Patanwala I, et al. Non-opioid pain management in benign minimally invasive hysterectomy: A systematic review. Am J Obstet Gynecol. 2016. PMID: 28043841. doi:10.1016/j.ajog.2016.12.175

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。